ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
5.21
-0.43 (-7.62%)
At close: Oct 31, 2024, 4:00 PM
5.14
-0.07 (-1.34%)
After-hours: Oct 31, 2024, 7:52 PM EDT
ImmunityBio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ImmunityBio stock have an average target of 17.38, with a low estimate of 4.75 and a high estimate of 30. The average target predicts an increase of 233.59% from the current stock price of 5.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ImmunityBio stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +475.82% | Oct 23, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6 → $4.75 | Hold | Maintains | $6 → $4.75 | -8.83% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +15.16% | Apr 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | -4.03% | Mar 25, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $10 → $4 | Buy → Hold | Downgrades | $10 → $4 | -23.22% | May 12, 2023 |
Financial Forecast
Revenue This Year
14.91M
from 622.00K
Increased by 2,297.43%
Revenue Next Year
124.29M
from 14.91M
Increased by 733.49%
EPS This Year
-0.88
from -1.15
EPS Next Year
-0.75
from -0.88
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 16.9M | 136.6M | 325.3M |
| Avg | 14.9M | 124.3M | 295.9M |
| Low | 12.8M | 111.3M | 265.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2,624.6% | 816.1% | 161.7% |
| Avg | 2,297.4% | 733.5% | 138.1% |
| Low | 1,964.0% | 646.6% | 113.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.77 | -0.63 | -0.30 |
| Avg | -0.88 | -0.75 | -0.46 |
| Low | -0.97 | -0.86 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.